Compositions for the treatment and Prevention of the use of uninhibidor arterial Thrombosis and factor Xa alone or in combination with Antiplatelet drugs

摘要

1. The drug compounds with the characteristics of direct or indirect selective strong inhibitor of XA factor, combined with one or more platelet anticoagulant active compounds and possibly one or more drug acceptable vehicles, can perform the antiretroviral effect through the anti hematopoietin III. Pharmaceutical ingredients according to claim 1characterized in that they comprise an Iib / IIIa glycoprotein antagonist as platelet antiaggregant and methyl O- (2-deoxy-2-sulfoamino-6-O-sulfo-aD-glucopyranosyl) - (1-4) -O- (acid- β-D-glucopyranosyluronic) - (1-4) -O- (2-deoxy-2-sulfoamino-3,6-di-O-sulfo - aD-glucopyranosyl- (1-4) -O- (acid 2 -O-sulfo-aL-idopyranosyluronic) - (1-4) -deoxy-2-sulfoamino-6-O-sulfo-aD-glucopira-noside whose anion possesses structure (B) or one of its pharmaceutically acceptable salts, as an indirect selective factor Xa inhibitor.